Loading clinical trials...
Loading clinical trials...
Registry of CytoSorb Therapy in COVID-19 ICU Patients (CTC REGISTRY): Registry of Patient-level Clinical Data on CytoSorb Hemoadsorption Provided Via Integration of the CytoSorb Device Into Extracorporeal Membrane Oxygenation (ECMO), Continuous Renal Replacement Therapy (CRRT), or Hemoperfusion Extracorporeal Circuits in COVID-19 ICU Patients
Conditions
Interventions
CytoSorb 300 mL device
Locations
7
United States
Medical Center of Aurora
Aurora, Colorado, United States
University of Chicago Medicine
Chicago, Illinois, United States
Franciscan Health Indianapolis
Indianapolis, Indiana, United States
Baptist Memorial Hospital
Southaven, Mississippi, United States
New York University Medical Center
New York, New York, United States
West Virginia University
Morgantown, West Virginia, United States
Start Date
August 28, 2020
Primary Completion Date
January 20, 2022
Completion Date
January 20, 2022
Last Updated
February 9, 2024
NCT06631287
NCT05101213
NCT04565665
NCT06871293
NCT04978571
NCT06082518
Lead Sponsor
CytoSorbents, Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions